ERA OF NEW ANTICOAGULANTS IN THE TREATMENT OF NON-VALVULAR ATRIAL FIBRILLATION: PROSPECTS AND CHALLENGES

<p>Studies data on new anticoagulants, direct oral thrombin inhibitor (dabigatran) and direct inhibitors of coagulation factor Xa (rivaroxaban, apixaban), in the treatment of nonvalvular atrial fibrillation are presented. Effects of these drugs on cardiovascular events in atrial fibrillation a...

Full description

Bibliographic Details

Published in:	Рациональная фармакотерапия в кардиологии
Main Authors:	Z. M. Safiullina, S. V. Shalaev
Format:	Article
Language:	English
Published:	Столичная издательская компания 2015-09-01
Subjects:	антикоагулянты прямой пероральный ингибитор тромбина прямой ингибитор Xа фактора свёртывания
Online Access:	http://www.rpcardio.ru/jour/article/view/283